

HCIT & Life Sciences

The intersection of trends in HCIT and Life Sciences technology is a core thesis that we continue to applaud. These intersecting technologies not only allow providers to understand patients better, but can also deliver customized experiences in addition to elevating health care engagement.

Transactions

AGC Partners Advises Genesis Automation on Its Sale to Diversis Capital

AGC Partners Advises BroadJump on Its Acquisition by Curvo

"As an advisor to our company for several years, AGC became an integral part of our business, helping us evaluate a variety of strategic options. AGC's deep understanding of our goals and the market ultimately culminated in a successful sale. The AGC team's dedication, guidance, and expertise were instrumental in navigating the process and achieving this outstanding outcome."

Dan DeTorrice, President and CIO, BroadJump

AGC Partners Advises Yseop on Its Investment From Claret Capital Partners

Deal Team

Hugh Hoffman

Partner

Michael Howe

Partner

John Tinkham

Partner

Related Insights

© In the U.S., America’s Growth Capital, LLC dba AGC Partners, member FINRA/SIPC. In Europe, America’s Growth Capital Europe, LLP (Appointed Representative Alternatives St. James, LLP which is authorized and regulated by the Financial Conduct Authority). America’s Growth Capital Europe, LLP is a Limited Liability Partnership incorporated in England and Wales (OC368580). Its registered address is 6th Floor, 9 Appold Street, London EC2A 2AP. The testimonials contained herein may not be representative of the experience of other customers or clients. Testimonials are no guarantee of future performance or success. Deals marked with an “*” are non-AGC deals.

HCIT & Life Sciences